A PYMNTS Company

South Africa: Nestle told to sell baby formula patent to third party to buy Pfizer division

By  |  February 5, 2013

According to a news brief, South African regulators are reportedly recommending that Nestle sell its baby formula license for 20 years to a third party in order to ease competition concerns in its plans to acquire Pfizer’s baby nutrition division. The formulas whose patents are sold would also need to be sold under a different brand, reportedly to prevent price increases. Nestle has apparently accepted these requirements.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: Seeking Alpha

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.